市场调查报告书
商品编码
1463735
到 2030 年北美减重手术市场预测 - 区域分析 - 按类型和最终用户(医院和门诊手术中心)North America Bariatric Surgeries Market Forecast to 2030 - Regional Analysis - by Type and End User (Hospitals and Ambulatory Surgical Centers) |
2022年北美减重手术市场价值为47.7565亿美元,预计到2030年将达到152.8779亿美元;预计2022年至2030年CAGR为15.7%。
肥胖盛行率的增加推动了北美减重手术市场
体内脂肪堆积过多被称为肥胖,它会导致各种健康问题。当体重指数为25或以上时,就被认为是肥胖。肥胖是心血管疾病和糖尿病等各种健康状况的主要原因之一。饮食习惯和久坐生活方式的改变增加了全球肥胖的盛行率。很大一部分人食用高热量、高脂肪食物而体力活动有限,导致肥胖率增加。据世界卫生组织称,到 2022 年,全球约有 10 亿人肥胖,其中包括 3,900 万儿童、3.4 亿青少年和 6.5 亿成年人。有多种因素会影响体重并导致肥胖,例如遗传、行为、代谢和荷尔蒙。在某些情况下,肥胖可能是由医学原因引起的,例如甲状腺功能减退症、库欣氏症候群和普瑞德威利症候群。肥胖症的日益普及导致了各种健康问题。大多数肥胖者因社会孤立、残疾和工作成就较低而感到沮丧、羞耻和内疚,这影响了他们的生活品质。根据国家老化委员会 (NCOA) 2021 年报告,体重超重的成年人一生中患忧郁症的风险比未患有肥胖症的人高 55%。
为了克服上述条件并提高广大人口对肥胖后果的认识,对减重手术的需求正在增加,因为它有助于减轻体重。根据美国代谢和减肥外科学会的数据,2021 年美国总共进行了 262,893 例减肥手术,而 2020 年美国则进行了 198,651 例手术。因此,肥胖盛行率的增加以及对其后果的认识不断提高,增加了对减重手术的需求,推动了减重手术设备市场的发展。
北美减肥手术市场概况
根据美国、加拿大和墨西哥对北美减肥手术市场进行了分析。该地区的市场成长归因于肥胖人数的增加、产品批准的增加、减肥手术意识的增强以及运营商之间合併、合作和伙伴关係数量的增加。此外,肥胖相关合併症的发生率显着增加是减重手术需求增加的其他主要因素之一。由于胃束带和气球以及上述其他外科手术等技术的进步,美国的减重手术设备已显着成长。一些市场参与者正在采取有机策略来保持市场竞争力。例如,2021 年 5 月,Standard Bariatrics 宣布其新型 Titan SGS 吻合技术已获得美国食品药物管理局 (FDA) 的批准,该技术专为减肥袖状手术而设计。 Titan SGS 为执行袖状胃切除手术的外科医生提供了业界最长的 23 公分连续吻合钉切割线。
北美减重手术市场收入和 2030 年预测(百万美元)
北美减重手术市场细分
北美减重手术市场按类型、最终用户和国家进行细分。
根据类型,北美减重手术市场分为可调式胃带(AGB)、袖状胃切除术、胃绕道术、十二指肠开关胆胰分流术(bpd-ds)等。 2022 年,袖状胃切除术细分市场占据最大份额。
就最终用户而言,北美减重手术市场分为医院和门诊手术中心。 2022 年,医院细分市场将占据更大份额。
根据国家/地区,北美减肥手术市场分为美国、加拿大和墨西哥。 2022 年,美国主导北美减重手术市场。
Apollo Endosurgery Inc、Conmed Corp、Ethicon USA LLC、Integra LifeSciences Holdings Corp、Intuitive Surgical Inc、Medtronic Plc、Olympus Corp、Reshape Lifesciences Inc 和 Spatz FGIA Inc 是北美减肥手术市场的一些领先公司。
表中的内容
The North America bariatric surgeries market was valued at US$ 4,775.65 million in 2022 and is expected to reach US$ 15,287.79 million by 2030; it is estimated to grow at a CAGR of 15.7% from 2022 to 2030.
Increasing Prevalence of Obesity Fuels the North America Bariatric Surgeries Market
Excess amount of fat accumulation in the body is known as obesity, which can cause various health problems. When the body mass index is 25 or above, it is considered obesity. Obesity is one of the leading causes of various health conditions, such as cardiovascular disorders and diabetes. Changes in food habits and sedentary lifestyles have increased the prevalence of obesity on a global level. A large percentage of the population consuming high-calorie, high-fat food with limited physical activity has increased obesity rates. According to the World Health Organization, in 2022, ~1 billion people worldwide were obese, including 39 million children, 340 million adolescents, and 650 million adults. There are various factors, such as genetic, behavioral, metabolic, and hormonal, that influence body weight and can cause obesity. In some cases, obesity can be caused due to medical reasons such as hypothyroidism, Cushing syndrome, and Prader-Willi syndrome. The increasing prevalence of obesity leads to various health concerns. Most of the obese population experience depression, shame, and guilt about their social isolation, disability, and lower work achievement, which affects their quality of life. According to the National Council of Aging (NCOA) 2021 report, adults with excess weight had a 55% higher risk of developing depression in their lifetime than those who did not suffer from obesity.
To overcome the abovementioned conditions and increase awareness among large populations about the consequences of obesity, the demand for bariatric surgery is increasing as it helps in weight reduction. According to the American Society for Metabolic and Bariatric Surgery, there were a total of 262,893 bariatric surgeries performed in 2021 as compared to 198,651 surgeries in 2020 in the US. Therefore, increasing prevalence of obesity and rising awareness about its consequences have increased the demand for bariatric surgeries, driving the bariatric surgery devices market.
North America Bariatric Surgeries Market Overview
The North America bariatric surgeries market is analyzed based on the US, Canada, and Mexico. The market growth in the region is attributed to increasing obesity, rising product approvals, growing awareness about bariatric surgeries, and rising number of mergers, collaborations, and partnerships among the operating players. In addition, significantly growing incidences of obesity associated comorbidity are among the other leading factors escalating the demand for bariatric surgeries. Bariatric surgery devices in the US have grown significantly owing to advancements in technologies such as gastric bands & balloons and other surgical procedures mentioned above. Several market players are adopting organic strategies to stay competitive in the market. For instance, in May 2021, Standard Bariatrics announced that it had been cleared by the US Food and Drug Administration (FDA) for its novel Titan SGS stapling technology, designed precisely for bariatric sleeve surgery. The Titan SGS offers surgeons performing sleeve gastrectomy procedures the industry's longest continuous staple cutline of 23 cm.
North America Bariatric Surgeries Market Revenue and Forecast to 2030 (US$ Million)
North America Bariatric Surgeries Market Segmentation
The North America bariatric surgeries market is segmented into type, end user, and country.
Based on type, the North America bariatric surgeries market is categorized adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (bpd- ds), and others. The sleeve gastrectomy market segment held the largest share in 2022.
In terms of end user, the North America bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospitals segment held a larger share in 2022.
Based on country, the North America bariatric surgeries market is segmented the US, Canada, and Mexico. The US dominated the North America bariatric surgeries market in 2022.
Apollo Endosurgery Inc, Conmed Corp, Ethicon USA LLC, Integra LifeSciences Holdings Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, Reshape Lifesciences Inc, and Spatz FGIA Inc are some of the leading companies operating in the North America bariatric surgeries market.
Table of Content